5 min 
How AI in Pharma Can Help You Adapt and Grow
The U.S. administration’s latest executive order aims to reduce drug prices by as much as 59% to 90%. While this is a huge win for patients, it puts unprecedented pressure on pharma companies. The implications go far beyond pricing, raising important questions about how to sustain innovation, expand access, and evolve business models. All now with leaner budgets and tighter margins!
This means operational efficiency and smarter execution are no longer optional, they’re fundamental to staying competitive. AI and predictive intelligence are already playing a role here, helping commercial teams reduce friction, focus on what matters, and respond faster to change.However, the opportunity isn’t just in adopting AI in pharma, but in deploying it in a way that’s scalable and aligned with the unique complexity of pharma – where regulatory nuance, siloed data, and fast-moving markets demand tailored solutions.
Budget Pressures Are Rising Across the Board
Price cuts aren’t just a short-term hit – they’re changing how pharma plans, invests, and operates. With tighter margins and more unpredictable revenue, commercial teams must now demonstrate impact on every dollar spent, rethink salesforce deployment, and defend ROI across every engagement.
This pressure is already being felt and it’s about to intensify. Activities like costly in-person field visits, months-long planning timelines, and disconnected data sources create operational drag. These inefficiencies prevent teams from responding quickly to shifts in market conditions, HCP behavior, or patient needs at a time when agility is critical.
Growth depends on getting the right insights faster and turning them into action. It’s no longer about bigger budgets; it’s about smarter decisions. And this is where AI can help.
AI in Pharma Makes the Smartest Use of Your Team’s Time
Imagine trying to defend your current market share while launching a new product into a tougher, more regulated market – one reshaped by significant drug price cuts and tighter margins. The usual playbooks no longer apply, and commercial teams are now expected to achieve more with less.
Now imagine doing it while your competitor is already using AI to work faster and smarter – identifying high-value HCPs, spotting market shifts in real time, and acting before you even see the signal. That’s the competitive edge AI in pharma creates.
Without it, many teams are still stuck chasing reports, battling fragmented data, and reacting too late, missing opportunities in a market that demands speed and precision.
AI gives commercial teams a better path forward. Whether it’s defending share or accelerating a launch, AI in pharma enables faster, more informed action, helping teams stay ahead of shifts in HCP behavior, market dynamics, and patient trends.
AI can help you:
- Spot opportunities and risks sooner
- Automate time-consuming analysis
- Focus energy where it matters most.
It’s not just about doing more. It’s about doing what matters, and smartly using your team’s time with precision and speed.
Four Ways AI Delivers Real Commercial Impact
Here are four ways AI in pharma can deliver measurable impact across your commercial strategy:
- Smarter HCP Targeting
AI helps you focus your team on the highest-value HCPs and recommend not just who to reach, but when, how, and with what message.
Now you can move from spray-and-pray to smart precision marketing. Instead of wasting limited resources on broad outreach, teams can prioritize precision targeting where ROI is highest.
- Earlier Patient Discovery
AI helps you spot intervention points earlier, meaning sales reps reach patients who need treatment most, improving outcomes and brand loyalty.
With AI you can identify eligible patients sooner by linking real-world data, medical claims, and historical treatment journeys. Field teams can now identify hidden patient populations and engage providers at the right moment before missed opportunities or delayed diagnoses occur.
- Faster Field Execution & Productivity
With AI-powered real-time alerts replacing static dashboards, you can act faster.
Field teams now gain AI alerts when formulary status changes, prescribing behavior shifts, or new opportunities emerge. This means sales reps spend less time chasing leads and more time making high-impact moves.
- Less Time Wrangling Data
With GenAI you can move faster going from business questions to decisions in minutes, not weeks.
Commercial leaders can now explore complex scenarios, uncover insights, and make confident calls without waiting on IT or data teams. Learn more about how Generative AI is reshaping pharma decision-making: Unlocking the True Potential of GenAI in Pharma.
How Verix Helps You Tackle These Challenges
When pressure is high and every decision counts, bringing everything together in one specialized pharma platform becomes essential – no silos, no delays.
Verix’s Tovana platform is our AI-powered solution for optimizing pharma commercial strategy and execution. It unifies targeting, orchestration, forecasting, and patient insights into one seamless, streamlined environment.
It is purpose-built to help pharma commercial teams achieve more with less:
- Data-first approach: Integrates patient, HCP, HCO, and payer data to provide a unified, connected, accurate view of your market.
- Actionable and fast: Teams can access real-time insights, recommendations, and forecasts without relying on analysts or writing code. With ready-built models, it means teams can hit the ground running, accelerating deployment and driving value from day one.
- Purpose-built for pharma: Built specifically to navigate the industry’s unique data, regulatory, and operational complexity. That means faster onboarding, better compliance, and tools that align with how commercial and medical teams actually work.
- Adaptable at scale: Designed to support AI-driven decisions with your organization’s needs at scale, whether you’re launching in a new market, scaling a brand, or adjusting strategy mid-cycle.
The result: fewer delays, smarter execution, and a faster path to measurable impact.
AI Is How You Protect, Adapt and Lead in Today’s Evolving Market
Innovation won’t slow down, rather how we pursue it must change. With U.S. drug price cuts on the horizon, companies will need to do more with less. The path forward demands efficiency, agility, and decisions grounded in real-time data, not legacy assumptions.
This is where AI in pharma can help. AI gives pharma the ability to adapt with precision: to safeguard market share, act quickly on insights, and make every engagement count. It doesn’t replace your commercial team; it makes them do more with less!
At Verix, we believe commercial teams shouldn’t have to choose between innovation and efficiency. By turning complexity into clarity, our AI-powered platform helps pharma teams respond to change with confidence, speed, and strategic focus.
